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============

An outbreak of the novel coronavirus disease, COVID -19, started in Wuhan, China in December 2019([@bib19]). Due to its global spread, the World Health Organisation classified COVID-19 as a pandemic on March 11^th^ 2020([@bib10]). This led to the implementation of a 'lockdown' strategy in many countries to control the impact of the virus, with the United Kingdom (UK) entering its own lockdown on the 23^rd^ March([@bib3])**.** Despite these efforts, at the time of writing in the UK alone nearly 300000 people have been infected with over 40,000 deaths([@bib11]). This presents an unprecedented burden on the capacity of many healthcare systems to deal with the outbreak.

The UKs National Health Service (NHS) has been overhauled to help dedicate adequate resources and staff to the care of patients with COVID -19. This includes the cancellation of elective operations, the redeployment of staff from surgical to medical specialities and a focus on providing ventilators and personal protective equipment([@bib16]). The changes aimed to reduce the nosocomial spread of the virus or aid management of those infected with the virus therefore reduce its associated morbidity and mortality([@bib11]). Consequently, these adjustments have had a demonstrable effect on patients on the waiting list for potentially life changing operations, management of acute surgical presentations, and added significant costs to the NHS ([@bib17]),([@bib7]). At our hospital, a similar redistribution process occurred, in which trauma patients with hip fragility fractures were transferred to a 'local COVID free' hospital. The rationale for this operative pathway change was to enable the provision of 'COVID free' operating sites to reduce the risk of coronavirus spread in trauma operating and increase the bed capacity for COVID-19 patients in non-operating hospitals. Patients would be initially admitted at the presenting hospital and either transferred directly from the emergency department or admitted briefly for pain control and stabilisation before transfer. This would occur during daytime working hours. Post-operatively, patients would be discharged to their residence or back to the initial admitting hospital for ongoing management on a COVID- free ward. The arrangement would enable the operative hospital to stay COVID-19 free without inhibiting its operating capacity. This operative pathway change was challenging as patient transfers are complex undertakings, with a referral needing to take place between orthopaedic teams conditional on acceptable imaging and investigations as well as bed manager liaison and the ensuring of adequate transport being available. This could potentially increase times to surgery as well as increase the overall admission time period for these patients. Fragility fractures are a significant injury and therefore delays to surgery could adversely affect morbidity and mortality outcomes.

Over 60000 patients with hip fragility fractures present to hospitals every year, with an estimated cost to the NHS of over 2 billion pounds annually with patients who require very intensive nursing care input ([@bib8])^,^([@bib9]). These fractures are a significant cause of morbidity and mortality, with estimates of between 10 per cent and 30 percent mortality at 30 day and 1 year post injury respectively; with an ageing population this issue is likely to become more commonplace([@bib18]) ([@bib12])^,^ ([@bib13]). The significance of this injury has led to a target of fracture fixation emergently within 36 hours to reduce the complications associated with this injury([@bib6])**.** The focus on National Institute for Health and Clinical Excellence (NICE) target led improvements in managing this injury has improved the 30-day mortality to between 6 and 7% in recent years([@bib8])^,^([@bib14]).

The need to transfer care to another site and therefore possible delays in operative fixation have the potential to adversely affect adherence to NICE targets and post-operative outcomes. Locally, the redeployment of critical medical and nursing care from hip fragility fracture management to roles in intensive care and medical specialities led to the disruption of trauma operating pathways. Furthermore, the need for cross-site management disrupted the ability for multidisciplinary teams including physiotherapist, occupational therapists and orthopaedic nursing staff to risk assess and manage patients. This study analyses how local management pathway changes necessitated by the COVID-19 pandemic have affected the outcomes of patients undergoing hip fragility fracture operations. This has the overall aim of describing these outcomes to help inform future policy and management decisions should the current or further pandemics cause further disruption in the management of these injuries.

Methods {#sec2}
=======

Data collection and analysis {#sec2.1}
----------------------------

A single centre, retrospective analysis was performed for all patients who presented with hip fragility fractures for operative management between the 23^rd^ March and 29^th^ April 2020. Departmental trauma lists were used to identify hip fragility fracture presentations within the specified period. A software called Electronic Patient Record or 'EPR' was used to gather basic patient identification, operation data and post admission outcomes including if patients were repatriated. All patients included in this study who were operated on at a local tertiary referral centre had their corresponding inpatient data transferred to our records for review. Records were analysed for post- operative complications including mortality.

Patient outcomes with continuous variables were presented as a median with an interquartile range (IQR). Other outcomes were summarised and reported alongside the overall percentage (%). All-cause 30-day mortality was calculated from the day of presentation to hospital to the date of death.

A regression analysis was performed to ascertain if there was any significant relationship between the time to operation and length of stay and mortality outcomes. This analysis was conducted using the software STAT/IC 15.1.

Results {#sec3}
=======

35 patients presented with a hip fragility fracture for operative management between 23^rd^ March and 29^th^ April. One patient was excluded as no documentation of their admission details could be found, potentially due to administrative error. Therefore 34 patients met the inclusion criteria for analysis. The median patient age was 88 years old, with 10 (29%) of patients being male. All patients included had at least one comorbidity, with the most common being hypertension (53%), long term cognitive impairment (32%) and cardiovascular disease (29%). Right sided fractures comprised 50% of fractures and 65% of fractures were intracapsular. [Table 1](#tbl1){ref-type="table"} contains the patient characteristics and of those included in the study.Table 1patient demographicsTable 1Patient demographicsTotal patients (n)34Males n (%)10 (29)Age, median (IQR)88 (84-92)Comorbidities-None n (%)0 (0)-Hypertension n (%)18 (53)-Diabetes Mellitus n (%)4 (12)-Cardiovascular disease n (%)10 (29)-COPD/ Asthma n (%)3 (8)-Cerebrovascular/ peripheral vascular disease n (%)9 (26)-Chronic Kidney disease n (%)5 (15)-Dementia/ alzheimers n (%)11 (32)-Other n (%)25 (74)Right sided fracture (%)17 (50)Intracapsular fracture n (%)22 (65)Extracapsular fracture n (%)14 (35)Table 2patient outcomesTable 2Patient outcomesTotal number of patients operated on n (%)31 (91)Patient mortality prior to operation n (%)3 (9)Duration inpatient stay, median days (IQR)8 (5-17)Patients operated on within 36 hours n (%)15 (48)Duration from admission to operation median days (IQR)2 (1-2)Operation type12 (39)-Hemiarthroplasty n (%)4 (13)-Total hip replacement n (%)5 (16)-Intramedullary nailing n (%)10 (32)-Dynamic hip screw n (%)Patients repatriated back6 (21)Patient mortality post operation n (%)3 (10)30-day mortality from date of presentation n (%)6 (20)Duration from admission to mortality, median days (IQR)4 (3- 14)Figure 1data collection methodologyFigure 1

Of the 34 patients due for operative management, 31 underwent operations whilst 3 died prior to being operated on. The median inpatient stay was 8 days, and 48% of patients were operated on within 36 hours. The median duration in days from presentation to operation was two days. The most common operation type was a hip hemiarthroplasty (39%). 6 (21%) patients were repatriated back for ongoing rehabilitation or medical management. 3 patients died post operation, giving an overall 30-day all-cause mortality from the date of injury presentation of 20%. Regression analysis showed no significant relationship between either operating within 36 hours or the number of days to operation and length of stay or mortality rates (p \>0.05). Regarding the cause of the deaths, two patients had COVID as a possible contributing factor, one was confirmed COVID positive. One patient died of acute coronary syndrome, whilst two patients had no specific cause but a general decline in health.

Discussion {#sec4}
==========

Covid-19 necessitated a significant change in hip fragility fracture management at our local district general hospital. Only 48% of the patients were operated within 36 hours of presentation. The 30-day mortality rate was 20%, nearly three times recent national hip database reports ([@bib9]) ([@bib8]). Three of these patients died pre-operatively, whilst the three patients who died post operatively were operated on after 36 hours of presentation. Whilst not achieving statistical significance in regression analysis this higher than expected mortality can partly be attributed to the COVID pandemic which was given as a documented cause of death in three of the deaths seen in this study, two of whom died before being operated on. The COVID 19 pandemic continues to disrupt health systems and it is likely new methods will be needed to ensure safe operating([@bib5])^,^([@bib1])^,^ ([@bib15]).With the ongoing disturbance to the pathways, we would advise on being aware of the logistical issues delaying the management of these patients and determine appropriate measures to rectify this . The need for cross-site management, re-patriation and delays to surgery present difficulties for multi-disciplinary teams to assess patients; we would advise allocating specific discharge planning teams to focus on streamlining the admission pathways for hip fragility fractures. Also noted is the redeployment of trauma and orthopaedic nurses to other specialities; hip fragility fracture patients require intensive nursing and the increased risks highlighted by this study emphasise the need for management by dedicated nursing staff. Additionally robust early ortho geriatrician input in the perioperative period is vital in improving the management of a multi comorbid population; this has proved to be of significant benefit in improving patient outcomes.([@bib4]) Moreover, our data shows that in this particularly 'high risk' period it may be wise to counsel and consent patients and families with emphasis on the increased risks of morbidity and mortality related to both the pandemic and these operative delays.

Our study does have limitations. These include our small sample size which may have contributed to our outcome data not achieving statistical significance; we envision more data from other hospital trusts would help to expand on our findings. Another limitation included the lack of documentation found in the repatriated data, we were only able to ascertain discharge summaries and operation notes. Therefore, accurately identifying the events leading up to and the cause of death was difficult. Furthermore, due to the short follow up time a further study looking at the long-term mortality of those operated on during the COVID 19 pandemic as well as reviewing longer term postoperative complications would prove useful in discerning its impacts.

Our study demonstrates that the pandemic and changes to pathways have had a sizeable impact on meeting operating targets as well as the 30-day mortality of hip fragility fracture patients. Whilst of a small sample size, this is likely analogous with the experiences of other local hospitals; more studies are likely needed in this respect. The disruptions, restructuring of services and staff deployment as well as the risk posed by the virus itself are likely to continue for a considerable time, leading to unintended negative consequences as demonstrated in this study. These changes seen locally to operating pathways are not dissimilar to those outlined in other studies which focus on elective rather than issues surrounding trauma operating as discussed in this paper ([@bib5])^,^([@bib1])^,^ ([@bib15]). Furthermore, provision of personal protective equipment for nursing, operating and anaesthetic teams, Covid 19 testing for patients prior to surgery and a post-operative rehabilitation team are few of the challenges faced in this period. To prevent management delays, a focus on solving the logistical issues relating to multi centre management pathways is crucial. Furthermore, staff deployment must be an absolute priority for the hip fracture service along with provision of hip fracture operating lists in accordance with relative hip fracture workload. In addition, we believe that senior anaesthetic and surgeon led operating lists, rapid COVID swab testing for patients, appropriate trauma theatre staffing, ward care led by specialist hip fracture nurses, early ortho-geriatrician input in the perioperative setting, and a dedicated rehabilitation team to enable early discharge from hospital would be essential in improving outcomes and deliver a safe service. We also advise to counsel patients and relatives on the increased mortality risks during the COVID-19 pandemic as a part of informed consent to help increase awareness of the hazards of operating in this period. We believe that the multidisciplinary input as outlined above will ensure safe and effective care for this vulnerable group of patients.
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